ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1714

Avoidable Hospitalizations by Persons with Rheumatoid Arthritis: A Population-Based Study Using Administrative Data

Dani Contreras1, Claire Barber1, J. Antonio Avina-Zubieta2, Hude Quan1, Seungwon Lee1, James King1 and Cheryl Barnabe1, 1University of Calgary, Calgary, AB, Canada, 2Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada

Meeting: ACR Convergence 2024

Keywords: Access to care, Cohort Study, Epidemiology, Health Services Research, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Abstracts: Epidemiology & Public Health II

Session Type: Abstract Session

Session Time: 3:00PM-4:30PM

Background/Purpose: Ambulatory care sensitive conditions (ACSCs) are conditions where appropriate access to ambulatory care can reduce hospitalizations. People with rheumatoid arthritis (RA) are at higher risk for ACSC hospitalizations due to consequences of systemic inflammation and insufficient management of the condition in ambulatory practice. This project aims to estimate rates of avoidable hospitalizations by persons with RA relative to the general population.

Methods: We conducted a retrospective cohort study in Alberta, Canada, a province of ~4.6M with universal health coverage, of individuals meeting a validated case definition for RA based on ICD codes in years 2002-2023. Controls were identified by matching age, sex, and date of diagnosis. There was a 5-year washout period to identify incident RA cases. We identified ACSCs using established ICD codes from the Canadian Institute for Health Information (including grand mal seizures, chronic lower respiratory diseases, asthma, diabetes, heart failure and pulmonary edema, hypertension, and angina). Incidence rate ratios (IRR) up to 5 years from the date of diagnosis were calculated using a multivariable regression model adjusting for age, sex, and location of residence. A Cox proportional hazards model (p < 0.05) was used to identify predictors of avoidable hospitalizations, including sex, age at admission, location of residence, attachment to a family physician or rheumatologist, exposure to corticosteroid and disease-modifying anti-rheumatic drugs (DMARDs), presence of comorbidities, and whether these comorbidities are ACSCs.

Results: From a prevalent RA cohort composed of 52,596 individuals and 210,384 controls, there were 25,281 cases and 70,313 controls with hospitalizations during the study period (Table 1). The number of hospitalizations was 83,811 in cases and 190,304 in controls, where 8.3% and 9.1% were for all ACSCs combined, respectively. Among cases, the highest frequency of ACSC hospitalizations was for chronic lower respiratory diseases at 3.8% (3202/83811) (Figure 1).

Cases had 1.12 times the risk of hospitalization for heart failure and pulmonary edema compared to those without RA (IRR 1.12, 95% 1.01, 1.25). Significant predictors of ACSC hospitalizations for RA cases were increasing age, not having seen a physician at any point since diagnosis, being from a rural location, and having comorbid conditions, especially if the comorbid condition is an ACSC (HR 7.34, 95% CI 6.25, 8.62) (Table 2).

Conclusion: Persons with RA are at a higher risk of avoidable hospitalizations in the first 5 years after diagnosis compared to those without RA. Improved ambulatory care access and quality, inclusive of primary care and subspecialty care, is needed to prevent unnecessary hospitalizations and reduce burden on the acute care system.

Supporting image 1

Table 1. Characteristics of cases and controls with hospitalizations from 2007_2023.

Supporting image 2

Figure 1. Frequency of any Ambulatory Care Sensitive Condition (ACSC) admissions, and individual ACSC admissions, as a proportion of all hospitalizations, in cases and controls.

Supporting image 3

Table 2. Predictors of avoidable hospitalizations among RA cases, for any ACSC.


Disclosures: D. Contreras: None; C. Barber: None; J. Avina-Zubieta: None; H. Quan: None; S. Lee: None; J. King: None; C. Barnabe: Amgen, 6, Janssen, 6.

To cite this abstract in AMA style:

Contreras D, Barber C, Avina-Zubieta J, Quan H, Lee S, King J, Barnabe C. Avoidable Hospitalizations by Persons with Rheumatoid Arthritis: A Population-Based Study Using Administrative Data [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/avoidable-hospitalizations-by-persons-with-rheumatoid-arthritis-a-population-based-study-using-administrative-data/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/avoidable-hospitalizations-by-persons-with-rheumatoid-arthritis-a-population-based-study-using-administrative-data/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology